Moderna Therapeutics modernatx.com


Public list: Synthetic Biology (152) Pharma Startups (4740) Healthcare Horizons (27) Cancer Therapeutics (1146)

Moderna Therapeutics (NASDAQ:MRNA) is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA. The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.

Moderna Therapeutics (NASDAQ:MRNA) is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA. The company creates synthetic mRNA that can be injected into patients to help ...Show all

Company (IPO / Went public)

Phone: 617-714-6500

Fax:

200 Technology Square

Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Moderna Therapeutics $2573.2M Dec 7, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Moderna Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
AstraZenecaCorporationCambridge, England, United KingdomCorporate Minority - II, Series E
Alexion PharmaceuticalsCorporationCheshire, Connecticut, United StatesSeries F, Series E, Series D
Abu Dhabi Investment AuthoritySovereign Wealth FundUnited Arab EmiratesSeries G
ArrowMark PartnersAsset/Investment ManagementDenver, Colorado, United StatesSeries G
Alexandria Venture InvestmentsCorporate VenturePasadena, California, United StatesSeries G
See all 23 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Engineered nucleic acids and methods of use thereof Aug 26, 2016 Apr 10, 2018 Patent
Polynucleotide compositions containing amino acids Sep 12, 2014 Mar 27, 2018 Patent
Modified polynucleotides for the production of cosmetic proteins and peptides Mar 09, 2013 Jan 30, 2018 Patent
Nucleic acid vaccines Apr 05, 2016 Jan 23, 2018 Patent
Modified polynucleotides for the production of proteins Nov 13, 2015 Nov 28, 2017 Patent
See all 132 patents